Published in J Interv Card Electrophysiol on February 01, 2004
Implantable rhythm management device failures and patient/physician notification: a simmering cauldron boils over. J Interv Card Electrophysiol (2005) 0.79
Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm (2005) 1.94
NASPE policy statement on catheter ablation: personnel, policy, procedures, and therapeutic recommendations. Pacing Clin Electrophysiol (2003) 1.20
Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persistent atrial fibrillation. J Interv Card Electrophysiol (2011) 1.09
Clinical trials of antiarrhythmic therapies and optimizing health care resource deployment: the need for a paradigm shift. J Interv Card Electrophysiol (2012) 1.04
International consensus on nomenclature and classification of atrial fibrillation: A collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol (2003) 0.98
A truly new view from the summit: from translational science to outcomes research in clinical arrhythmology. J Interv Card Electrophysiol (2010) 0.85
Impact of "hybrid therapy" on long-term rhythm control and arrhythmia related hospitalizations in patients with drug-refractory persistent and permanent atrial fibrillation. J Interv Card Electrophysiol (2007) 0.85
Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation. J Interv Card Electrophysiol (2002) 0.83
Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation. Am J Cardiol (2004) 0.81
Bundle branch block and cardiac resynchronization therapy: do we need to look further before we leap? J Interv Card Electrophysiol (2003) 0.80
Implantable rhythm management device failures and patient/physician notification: a simmering cauldron boils over. J Interv Card Electrophysiol (2005) 0.79
Calamities and cardiac arrhythmias: the medical and scientific impact of epidemics of suffering. J Interv Card Electrophysiol (2002) 0.79
Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation. Am J Cardiol (2003) 0.79
A statement on ethics from the HEART Group. JACC Cardiovasc Imaging (2008) 0.78
Dual site right atrial pacing can improve the impact of standard dual chamber pacing on atrial and ventricular mechanical function in patients with symptomatic atrial fibrillation: further observations from the dual site atrial pacing for prevention of atrial fibrillation trial. J Interv Card Electrophysiol (2005) 0.77
Left atrial reverse remodeling and prevention of progression of atrial fibrillation with atrial resynchronization device therapy utilizing dual-site right atrial pacing in patients with atrial fibrillation refractory to antiarrhythmic drugs or catheter ablation. J Interv Card Electrophysiol (2014) 0.77
Prophylactic ICDs: can (and will) the medical marketplace decide their role? J Interv Card Electrophysiol (2005) 0.75
Federal guidelines for prophylactic ICD therapy in high risk populations for sudden cardiac death: is this a necessary course correction? J Interv Card Electrophysiol (2005) 0.75
Implantable cardioverter-defibrillators in cardiovascular care: technologic advances and new indications. Curr Opin Crit Care (2003) 0.75
Peering through the looking glass: electrical therapy for atrial fibrillation in 2004--where do we stand? J Cardiovasc Electrophysiol (2004) 0.75
Survival of antiarrhythmic or implantable cardioverter defibrillator treated patients with varying degrees of left ventricular dysfunction who survived malignant ventricular arrhythmias. J Cardiovasc Electrophysiol (2002) 0.75
Atrial fibrillation: is the fog lifting? J Interv Card Electrophysiol (2006) 0.75
Proceedings of the 7th International Symposium on Interventional Electrophysiology. Foreword. J Interv Card Electrophysiol (2014) 0.75
Every man and woman's guide to cardiac arrhythmias: what should Mr. & Ms. John Q Public know? J Interv Card Electrophysiol (2002) 0.75
Twenty years of interventional cardiac electrophysiology: Meeting future challenges with continuing innovations. J Interv Card Electrophysiol (2011) 0.75
Real time online imaging for interventional electrophysiologists: many directions and extraordinary opportunities. J Interv Card Electrophysiol (2006) 0.75
Implantable defibrillators configured for hybrid therapy of persistent and permanent atrial fibrillation: initial clinical experience with a novel lead system. J Interv Card Electrophysiol (2005) 0.75
The leadless defibrillator or the return of the subcutaneous electrode: episode III in the ICD saga? J Interv Card Electrophysiol (2005) 0.75
Implantable defibrillators for heart failure: a siren's song or a brave new world? J Interv Card Electrophysiol (2002) 0.75
Berndt Lüderitz (1940-present). J Interv Card Electrophysiol (2005) 0.75
Intra-cardiac echocardiography guided cardioversion to help interventional procedures (ICE-CHIP) study: study design and methods. J Interv Card Electrophysiol (2005) 0.75